These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20158609)

  • 1. Does local sympathetic atrophy contribute to splanchnic vasodilation in portal hypertension?
    Møller S; Stauber RE
    Liver Int; 2010 Apr; 30(4):499-501. PubMed ID: 20158609
    [No Abstract]   [Full Text] [Related]  

  • 2. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M; Martell M; Raurell I; Ezkurdia N; Cuenca S; Hernández-Losa J; Esteban R; Guardia J; Bosch J; Genescà J
    Liver Int; 2010 Apr; 30(4):593-602. PubMed ID: 19968782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of portal hypertension.
    Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC
    Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockage of the afferent sensitive pathway prevents sympathetic atrophy and hemodynamic alterations in rat portal hypertension.
    Ezkurdia N; Coll M; Raurell I; Rodriguez S; Cuenca S; González A; Guardia J; Esteban R; Genescà J; Martell M
    Liver Int; 2012 Sep; 32(8):1295-305. PubMed ID: 22292477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M; Genescà J; Raurell I; Rodríguez-Vilarrupla A; Mejías M; Otero T; Oria M; Esteban R; Guardia J; Bosch J; Martell M
    J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
    Heinemann A; Schuligoi R; Lippe IT; Stauber RE
    Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Portal hypertension and angiogenesis].
    Stumm M; Sieber C
    Schweiz Med Wochenschr; 2000 Feb; 130(7):233-9. PubMed ID: 10719714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulatory effects of graded diversion of portal blood flow to the systemic circulation in rats: role of nitric oxide.
    Bernadich C; Bandi JC; Piera C; Bosch J; Rodes J
    Hepatology; 1997 Aug; 26(2):262-7. PubMed ID: 9252132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of bile acids in splanchnic hemodynamic response to chronic portal hypertension.
    Thomas SH; Joh T; Benoit JN
    Dig Dis Sci; 1991 Sep; 36(9):1243-8. PubMed ID: 1893807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splanchnic and systemic vasodilation: the experimental models.
    Wiest R
    J Clin Gastroenterol; 2007; 41 Suppl 3():S272-87. PubMed ID: 17975477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension.
    Wiest R; Jurzik L; Herold T; Straub RH; Schölmerich J
    Peptides; 2007 Feb; 28(2):396-404. PubMed ID: 17194504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiology of the portal system and physiopathology of portal hypertension].
    Lebrec D
    Rev Prat; 1990 Jun; 40(16):1450-3. PubMed ID: 2193365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of portal hypertension.
    Gupta TK; Chen L; Groszmann RJ
    Clin Liver Dis; 1997 May; 1(1):1-12. PubMed ID: 15562664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of splanchnic vascular sensitivity to angiotensin II.
    Wu YP; Li SS; Campbell KA; Sitzmann JV
    Surgery; 1991 Aug; 110(2):162-8. PubMed ID: 1907031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased blood flow through the portal system in cirrhotic rats.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of portal hypertension.
    Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin production in acute, chronic, and long-term experimental portal hypertension.
    Sitzmann JV; Campbell K; Wu Y; St Clair C
    Surgery; 1994 Mar; 115(3):290-4. PubMed ID: 8128353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis in portal hypertension: involvement in increased splanchnic blood flow and collaterals?
    Geerts AM; Colle I
    Acta Clin Belg; 2007; 62(5):271-5. PubMed ID: 18229459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.